| 1 |
David B. Andersen |
Intel |
35 |
| 2 |
John W. Komp |
Covidien Lp |
26 |
| 3 |
Dale Hill |
Proterra Ag |
19 |
| 3 |
James Densmore Copp |
Akebia Therapeutics |
19 |
| 3 |
Robert Ashley |
Collagenex Pharmaceuticals |
19 |
| 3 |
Donald J. Samuels |
IBM |
19 |
| #7 |
Charles T. Lenzmeier |
Microsoft |
10 |
| #7 |
Josef Erlebach |
— |
10 |
| #9 |
Thomas J. Balkany |
Advanced Bionics Ag |
8 |
| #9 |
Stuart G. Gordon |
Agriforce Growing Systems |
8 |
| #11 |
Daniel Joseph Paluska |
MIT |
7 |
| #12 |
John Land Le Coq |
Fishpond |
6 |
| #12 |
Burton Simon |
Unknown |
6 |
| #14 |
Randy Thomas Antelo |
GE |
5 |
| #14 |
Fintan Doyle |
Research In Motion Limited |
5 |
| #14 |
David Pytel |
Flowvision |
5 |
| #17 |
Mathew Sherwood |
— |
4 |
| #17 |
James Copp |
Aerpio Pharmaceuticals |
4 |
| #17 |
Mark Joseph Mathis |
— |
4 |
| #17 |
Trygve Berge |
— |
4 |
| #21 |
William R. Epply |
— |
3 |
| #21 |
John Land LeCoq |
Fishpond |
3 |
| #21 |
Erika Karplus |
Proteus Digital Health |
3 |
| #21 |
Richard K. Solomon |
— |
3 |
| #21 |
Alex Renner |
Oklo |
3 |
| #21 |
Scott Carlson |
— |
3 |
| #27 |
Carl D Coy |
— |
2 |
| #27 |
William J. Freund |
— |
2 |
| #27 |
Clarke B. Evans |
— |
2 |
| #27 |
Bruce Ruff |
— |
2 |
| #27 |
Ram Pattisapu |
— |
2 |
| #27 |
Paul Lippe |
— |
2 |
| #27 |
Peter Klauser |
Amsted Rail Company |
2 |
| #27 |
Jay Harlan |
HP |
2 |
| #27 |
Phillip Hilgert |
Qwest Communications International |
2 |
| #27 |
Graham Bryan Pritchett |
— |
2 |
| #27 |
Allison Olenginski |
— |
2 |
| #27 |
Danny W. Akers, II |
— |
2 |
| #27 |
Kellie C. Akers |
— |
2 |
| #27 |
Gregory William Taylor |
— |
2 |
| #41 |
Tom Warnes |
— |
1 |
| #41 |
Stephen H. Finnis |
— |
1 |
| #41 |
Padraic J. Cassidy |
— |
1 |
| #41 |
Steven R. Link |
Unknown |
1 |
| #41 |
Leonard N. Hill |
Cyprus Amax Minerals |
1 |
| #41 |
Kenneth L. Shackles, Jr. |
— |
1 |
| #41 |
Thomas C. Lacy |
— |
1 |
| #41 |
Alex Bomareto |
— |
1 |
| #41 |
Gregory Morrell |
Unknown |
1 |
| #41 |
Brian Eisemann |
— |
1 |